世界の統合失調症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Schizophrenia Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5127 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、統合失調症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（第一世代抗精神病薬、第二世代抗精神病薬、第三世代抗精神病薬）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・統合失調症治療薬の市場動向 ・企業の競争状況、市場シェア ・統合失調症治療薬の種類別市場規模（第一世代抗精神病薬、第二世代抗精神病薬、第三世代抗精神病薬） ・統合失調症治療薬の用途別市場規模（病院、クリニック、その他） ・統合失調症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・統合失調症治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・統合失調症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・統合失調症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・統合失調症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Eli Lilly、GlaxoSmithKline、Johnson & Johnson、Alkermes、AbbVie、Amgen、Bristol-Myers Squibb） ・結論

Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient’s condition.
The second-generation antipsychotic drugs segment accounted for the majority market shares because these drugs involve less side effects in comparison to their predecessors. The second-generation antipsychotic drugs are also called as atypical antipsychotic drugs. The increased efficacy and reduced side effects of these drugs improves the negative symptoms, decreases extrapyramidal side-effects (EPSE), and normalizes the level of prolactin. The improvement in negative and cognitive symptoms and the reduction in occurrences of EPSE is attributed to their antagonizing action on serotonin or 5-HT2A receptors. This in turn, will boost the segment’s growth throughout the estimated period.

Market Analysis and Insights: Global Schizophrenia Therapeutics Market
The global Schizophrenia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Schizophrenia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Schizophrenia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Schizophrenia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Schizophrenia Therapeutics market.

Global Schizophrenia Therapeutics Scope and Market Size
Schizophrenia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Schizophrenia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
First-Generation Antipsychotic Drugs
Second-Generation Antipsychotic Drugs
Third-Generation Antipsychotic Drugs

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Alkermes
AbbVie
Amgen
Bristol-Myers Squibb

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Schizophrenia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 First-Generation Antipsychotic Drugs
1.2.3 Second-Generation Antipsychotic Drugs
1.2.4 Third-Generation Antipsychotic Drugs
1.3 Market by Application
1.3.1 Global Schizophrenia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Schizophrenia Therapeutics Market Perspective (2016-2027)
2.2 Schizophrenia Therapeutics Growth Trends by Regions
2.2.1 Schizophrenia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Schizophrenia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Schizophrenia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Schizophrenia Therapeutics Industry Dynamic
2.3.1 Schizophrenia Therapeutics Market Trends
2.3.2 Schizophrenia Therapeutics Market Drivers
2.3.3 Schizophrenia Therapeutics Market Challenges
2.3.4 Schizophrenia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Schizophrenia Therapeutics Players by Revenue
3.1.1 Global Top Schizophrenia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Schizophrenia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Schizophrenia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Schizophrenia Therapeutics Revenue
3.4 Global Schizophrenia Therapeutics Market Concentration Ratio
3.4.1 Global Schizophrenia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Schizophrenia Therapeutics Revenue in 2020
3.5 Schizophrenia Therapeutics Key Players Head office and Area Served
3.6 Key Players Schizophrenia Therapeutics Product Solution and Service
3.7 Date of Enter into Schizophrenia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Schizophrenia Therapeutics Breakdown Data by Type
4.1 Global Schizophrenia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Schizophrenia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Schizophrenia Therapeutics Breakdown Data by Application
5.1 Global Schizophrenia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Schizophrenia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Schizophrenia Therapeutics Market Size (2016-2027)
6.2 North America Schizophrenia Therapeutics Market Size by Type
6.2.1 North America Schizophrenia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Schizophrenia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Schizophrenia Therapeutics Market Size by Type (2016-2027)
6.3 North America Schizophrenia Therapeutics Market Size by Application
6.3.1 North America Schizophrenia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Schizophrenia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Schizophrenia Therapeutics Market Size by Application (2016-2027)
6.4 North America Schizophrenia Therapeutics Market Size by Country
6.4.1 North America Schizophrenia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Schizophrenia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Schizophrenia Therapeutics Market Size (2016-2027)
7.2 Europe Schizophrenia Therapeutics Market Size by Type
7.2.1 Europe Schizophrenia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Schizophrenia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Schizophrenia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Schizophrenia Therapeutics Market Size by Application
7.3.1 Europe Schizophrenia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Schizophrenia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Schizophrenia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Schizophrenia Therapeutics Market Size by Country
7.4.1 Europe Schizophrenia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Schizophrenia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Schizophrenia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Schizophrenia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Schizophrenia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Schizophrenia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Schizophrenia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Schizophrenia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Schizophrenia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Schizophrenia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Schizophrenia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Schizophrenia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Schizophrenia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Schizophrenia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Schizophrenia Therapeutics Market Size (2016-2027)
9.2 Latin America Schizophrenia Therapeutics Market Size by Type
9.2.1 Latin America Schizophrenia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Schizophrenia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Schizophrenia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Schizophrenia Therapeutics Market Size by Application
9.3.1 Latin America Schizophrenia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Schizophrenia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Schizophrenia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Schizophrenia Therapeutics Market Size by Country
9.4.1 Latin America Schizophrenia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Schizophrenia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Schizophrenia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Schizophrenia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Schizophrenia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Schizophrenia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Schizophrenia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Schizophrenia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Schizophrenia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Schizophrenia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Schizophrenia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Schizophrenia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Schizophrenia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Schizophrenia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Schizophrenia Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Schizophrenia Therapeutics Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Schizophrenia Therapeutics Introduction
11.2.4 Eli Lilly Revenue in Schizophrenia Therapeutics Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Schizophrenia Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Schizophrenia Therapeutics Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Schizophrenia Therapeutics Introduction
11.4.4 Johnson & Johnson Revenue in Schizophrenia Therapeutics Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Alkermes
11.5.1 Alkermes Company Details
11.5.2 Alkermes Business Overview
11.5.3 Alkermes Schizophrenia Therapeutics Introduction
11.5.4 Alkermes Revenue in Schizophrenia Therapeutics Business (2016-2021)
11.5.5 Alkermes Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Schizophrenia Therapeutics Introduction
11.6.4 AbbVie Revenue in Schizophrenia Therapeutics Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Schizophrenia Therapeutics Introduction
11.7.4 Amgen Revenue in Schizophrenia Therapeutics Business (2016-2021)
11.7.5 Amgen Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Schizophrenia Therapeutics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Schizophrenia Therapeutics Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Schizophrenia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of First-Generation Antipsychotic Drugs
Table 3. Key Players of Second-Generation Antipsychotic Drugs
Table 4. Key Players of Third-Generation Antipsychotic Drugs
Table 5. Global Schizophrenia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Schizophrenia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Schizophrenia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Schizophrenia Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Schizophrenia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Schizophrenia Therapeutics Market Share by Regions (2022-2027)
Table 11. Schizophrenia Therapeutics Market Trends
Table 12. Schizophrenia Therapeutics Market Drivers
Table 13. Schizophrenia Therapeutics Market Challenges
Table 14. Schizophrenia Therapeutics Market Restraints
Table 15. Global Schizophrenia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Schizophrenia Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Schizophrenia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Schizophrenia Therapeutics as of 2020)
Table 18. Ranking of Global Top Schizophrenia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Schizophrenia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Schizophrenia Therapeutics Product Solution and Service
Table 22. Date of Enter into Schizophrenia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Schizophrenia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Schizophrenia Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Schizophrenia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Schizophrenia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Schizophrenia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Schizophrenia Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Schizophrenia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Schizophrenia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Schizophrenia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Schizophrenia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Schizophrenia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Schizophrenia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Schizophrenia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Schizophrenia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Schizophrenia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Schizophrenia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Schizophrenia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Schizophrenia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Schizophrenia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Schizophrenia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Schizophrenia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Schizophrenia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Schizophrenia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Schizophrenia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Schizophrenia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Schizophrenia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Schizophrenia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Schizophrenia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Schizophrenia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Schizophrenia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Schizophrenia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Schizophrenia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Schizophrenia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Schizophrenia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Schizophrenia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Schizophrenia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Schizophrenia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Schizophrenia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Schizophrenia Therapeutics Product
Table 65. AstraZeneca Revenue in Schizophrenia Therapeutics Business (2016-2021) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. Eli Lilly Company Details
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Schizophrenia Therapeutics Product
Table 70. Eli Lilly Revenue in Schizophrenia Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Eli Lilly Recent Development
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Schizophrenia Therapeutics Product
Table 75. GlaxoSmithKline Revenue in Schizophrenia Therapeutics Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Schizophrenia Therapeutics Product
Table 80. Johnson & Johnson Revenue in Schizophrenia Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Johnson & Johnson Recent Development
Table 82. Alkermes Company Details
Table 83. Alkermes Business Overview
Table 84. Alkermes Schizophrenia Therapeutics Product
Table 85. Alkermes Revenue in Schizophrenia Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Alkermes Recent Development
Table 87. AbbVie Company Details
Table 88. AbbVie Business Overview
Table 89. AbbVie Schizophrenia Therapeutics Product
Table 90. AbbVie Revenue in Schizophrenia Therapeutics Business (2016-2021) & (US$ Million)
Table 91. AbbVie Recent Development
Table 92. Amgen Company Details
Table 93. Amgen Business Overview
Table 94. Amgen Schizophrenia Therapeutics Product
Table 95. Amgen Revenue in Schizophrenia Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Amgen Recent Development
Table 97. Bristol-Myers Squibb Company Details
Table 98. Bristol-Myers Squibb Business Overview
Table 99. Bristol-Myers Squibb Revenue in Schizophrenia Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Bristol-Myers Squibb Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Schizophrenia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. First-Generation Antipsychotic Drugs Features
Figure 3. Second-Generation Antipsychotic Drugs Features
Figure 4. Third-Generation Antipsychotic Drugs Features
Figure 5. Global Schizophrenia Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Schizophrenia Therapeutics Report Years Considered
Figure 10. Global Schizophrenia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Schizophrenia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Schizophrenia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Schizophrenia Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Schizophrenia Therapeutics Market Share by Players in 2020
Figure 15. Global Top Schizophrenia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Schizophrenia Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Schizophrenia Therapeutics Revenue in 2020
Figure 17. Global Schizophrenia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Schizophrenia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Schizophrenia Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Schizophrenia Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Schizophrenia Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Schizophrenia Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Schizophrenia Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Schizophrenia Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Schizophrenia Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Schizophrenia Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Schizophrenia Therapeutics Market Share by Region (2016-2027)
Figure 39. China Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Schizophrenia Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Schizophrenia Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Schizophrenia Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Schizophrenia Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Schizophrenia Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Schizophrenia Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Schizophrenia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AstraZeneca Revenue Growth Rate in Schizophrenia Therapeutics Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Schizophrenia Therapeutics Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Schizophrenia Therapeutics Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Schizophrenia Therapeutics Business (2016-2021)
Figure 62. Alkermes Revenue Growth Rate in Schizophrenia Therapeutics Business (2016-2021)
Figure 63. AbbVie Revenue Growth Rate in Schizophrenia Therapeutics Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Schizophrenia Therapeutics Business (2016-2021)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Schizophrenia Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---